Ning Ren

机构：Zhejiang Chinese Medical University, Sun Yat-sen University, Fudan University, Fudan University Shanghai Cancer Center, Zhejiang Provincial Hospital of TCM, Minhang District Central Hospital, Zhongshan Hospital, The First Affiliated Hospital, Sun Yat-sen University, Hangzhou Hospital of Traditional Chinese Medicine, Ministry of Education, Tianjin Chest Hospital, Ministry of Agriculture, Hebei University, Tianjin Medical University · ORCID：0000-0001-9776-2471

发表论文 171 篇 · 总被引 5010 次 · h-index 41

代表论文

• LCAT deficiency promotes hepatocellular carcinoma progression and lenvatinib resistance by promoting triglyceride catabolism and fatty acid oxidation (2025 · Cancer Letters · 被引 14)
• WWOX tuning of oleic acid signaling orchestrates immunosuppressive macrophage polarization and sensitizes hepatocellular carcinoma to immunotherapy (2024 · Journal for ImmunoTherapy of Cancer · 被引 12)
• The Role of Post-Translational Modifications in Necroptosis (2025 · Biomolecules · 被引 11)
• FGFR2 fusion/rearrangement is associated with favorable prognosis and immunoactivation in patients with intrahepatic cholangiocarcinoma (2024 · The Oncologist · 被引 11)
• Cost-effectiveness of talazoparib for patients with germline BRCA1/2 mutated HER2-negative advanced breast cancer in China and the US (2024 · Scientific Reports · 被引 6)
• The Prognostic Significance of CTSV Expression in Patients with Hepatocellular Carcinoma (2024 · International Journal of General Medicine · 被引 5)